The above studies demonstrate that levels of Nrg4 are lower in individuals with the MUO-like obesity phenotype than in those with the MHO-like phenotype, and this may protect against metabolic disorders accompanied by excessive body weight. This evidence concerns the gene NRG4 and metabolic disease.